SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Cough and cold medication use by US children, 1999–2006: results for the Slone survey. Pediatrics 2008; 122(2): e323e329. DOI: 10.1542/peds.2008-0498
  • 2
    American Academy of Pediatrics. Committee on Drugs. Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics 1997; 99(6): 918920. DOI: 10.1542/peds.99.6.918
  • 3
    Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest 2006; 129 (1 Suppl): 260S283S. DOI: 10.1378/chest.129.1_ suppl.260S
  • 4
    Centers for Disease Control and Prevention (CDC). Infant deaths associated with cough and cold medications–two states, 2005. MMWR Morb Mortal Wkly Rep 2007; 56(1): 14.
  • 5
    FDA. Nonprescription Drug Advisory Committee Meeting: Cold, Cough, Allergy, Bronchodilator, Antiasthmatic Drug Products for the Over-the-counter Human Use (Memorandum). FDA, Division of Drug Risk Evaluation: Rockville, 2007; 29. http://www.fda.gov/Drugs/DrugSafety/ PublicHealthAdvisories/ucm051282.html [Accessed on 16 January 2009].
  • 6
    Consumer Healthcare Products Association. Makers of OTC cough and cold medicines announce voluntary withdrawal of oral infant medicines, Washington, DC. http://www.chpa-info.org/10_11_07. OralInfantMedicines.aspx [Accessed on 23 December 2008].
  • 7
    FDA. Public Health Advisory: nonprescription cough and cold medicine use in children. FDA CDER, Rockville, 2008. http://www.fda.gov/Cder/drug/advisory/cough_cold_2008.htm [Accessed on 23 December 2008].
  • 8
    Consumer Healthcare Products Association. Pediatric oral cough and cold medicines. http://www.chpa-info.org/media/resources/r_4519. pdf#search=%22pediatric%22. [Accessed on 29 April 2009].
  • 9
    FDA. Over the counter cough and cold medications for pediatric use; notice of public hearing. Fed Regist 2008; 73(165): 5003350036.
  • 10
    Tenenbein M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med 2005; 159: 557560. DOI: 10.1001/archpedi.159.6.557
  • 11
    Benson BE, Spyker DA, Troutman WG, Watson WA. TESS-based dose-response using pediatric clonidine exposures. Toxicol Appl Pharmacol 2006; 213(2): 145151. DOI: 10.1016/j.taap.2005.10.009
  • 12
    Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents. A report from the American Association of Poison Control Centers. Pediatrics 1992; 89: 9991006.
  • 13
    Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Giffin SL. 2008 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual report. Clin Toxicol. 2009; 47: 911–1084. DOI: 10.3109/15563650903438566
  • 14
    Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Heard SE. 2006 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol 2007; 45: 815–917. DOI: 10.1080/15563650701754763
  • 15
    Mrvos R, Walters D, Krenzelok EP. The media's influence on a poison center's call volume. Vet Human Toxicol 1999; 41(5): 329330.
  • 16
    LoVecchio F, Katz K, Watts , Pitera A. Media influence on poison center volume after 11 September 2001. Prehosp Disaster Med 2004; 19(2): 185.
  • 17
    Centers for Disease Control and Prevention (CDC). Acute respiratory illness linked to use of aerosol leather conditioner—Oregon, December 1992. MMWR Morb Mortal Wkly Rep 1993; 41(52–53): 965967.
  • 18
    Centers for Disease Control and Prevention (CDC). Flu season summary (30 September 2007–17 May 2008), Atlanta. http://www.cdc.gov/flu/about/qa/season.htm [Accessed on 26 April 2009].